tiprankstipranks
Karyopharm price target adjusted to $10 from $5 at Barclays
PremiumThe FlyKaryopharm price target adjusted to $10 from $5 at Barclays
1M ago
Karyopharm Therapeutics Reports Q1 2025 Earnings and Clinical Progress
Premium
Company Announcements
Karyopharm Therapeutics Reports Q1 2025 Earnings and Clinical Progress
1M ago
Karyopharm reports Q1 EPS ($2.77), consensus ($3.09)
Premium
The Fly
Karyopharm reports Q1 EPS ($2.77), consensus ($3.09)
1M ago
Karyopharm price target lowered to split-adjusted $15 from $75 at Piper Sandler
PremiumThe FlyKaryopharm price target lowered to split-adjusted $15 from $75 at Piper Sandler
3M ago
Karyopharm price target lowered to $54 from $75 at Baird
Premium
The Fly
Karyopharm price target lowered to $54 from $75 at Baird
4M ago
Karyopharm target adjusted to $7 from $56 at H.C. Wainwright
Premium
The Fly
Karyopharm target adjusted to $7 from $56 at H.C. Wainwright
4M ago
Karyopharm Therapeutics: Strong Financial Performance and Strategic Developments Justify Buy Rating
PremiumRatingsKaryopharm Therapeutics: Strong Financial Performance and Strategic Developments Justify Buy Rating
4M ago
Karyopharm Therapeutics Faces Financial Uncertainty Amid $1.6 Billion Deficit and Urgent Need for Funding
Premium
Company Announcements
Karyopharm Therapeutics Faces Financial Uncertainty Amid $1.6 Billion Deficit and Urgent Need for Funding
4M ago
Karyopharm’s 2024 Earnings and Clinical Progress
Premium
Company Announcements
Karyopharm’s 2024 Earnings and Clinical Progress
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100